Hargsoon Yoon
CEO
Space LiinTech
Space Lintech manufactures pharmaceuticals specifically designed for microgravity environments, utilizing specialized formulation techniques to ensure stability and efficacy in space. This addresses the challenge of providing effective medical treatments for astronauts in orbit, where traditional medications may not perform as intended.
- Aerospace
- Biotechnology
- Manufacturing / Industry 4.0
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Traditional pharmaceuticals may degrade or behave unpredictably in microgravity environments, posing challenges for astronaut healthcare during space missions. Formulations optimized for Earth's gravity may not maintain stability or deliver the intended therapeutic effects in space.
Solution
Space Lintech develops and manufactures pharmaceuticals specifically formulated for use in microgravity. The company utilizes specialized techniques to ensure drug stability, efficacy, and consistent delivery in space environments. Space Lintech provides integrated solutions for biomedical research and pharmaceutical manufacturing in space, addressing the unique challenges of providing medical treatments to astronauts.
Target Audience
The primary customers are space agencies, private spaceflight companies, and researchers conducting biomedical experiments in space.
Features
- Specialized formulation techniques to ensure drug stability in microgravity
- Pharmaceuticals designed for optimal efficacy in space environments
- Integrated solutions for space-based biomedical research
- Manufacturing processes tailored for microgravity conditions